TABLE 2

Presentation of the pulmonary outcomes at the 3- and 12-month follow-up visits after hospital discharge for COVID-19

3-month visit12-month visit
nnp-value
Self-reported dyspnoea2042110.25
 mMRC 099 (48)107 (51)
 mMRC 164 (31)70 (33)
 mMRC ≥241 (20)34 (16)
Exercise capacity
 6MWD m190542±123174570±1090.01
 6MWD % predicted18599±21174114±33<0.001
 6MWD <LLN1905 (3)1748 (5)0.02
Spirometry
 FVC L2443.8±1.12213.9±1.10.30
 FVC % predicted24495±1422196±140.06
 FVC <LLN24421 (9)22118 (8)0.81
 FEV1 L2442.9±0.92213.9±1.10.62
 FEV1 % predicted24493±1622194±150.10
 FEV1 <LLN24428 (11)22117 (8)0.13
Diffusion capacity of the lungs
DLCO mmol min−1 kPa−12427.3±2.22187.6±2.1<0.001
DLCO % predicted24187±1821391±16<0.001
DLCO <LLN24261 (25)21838 (17)<0.001
DLCO 60–79% predicted24145 (19)21624 (11)<0.001
DLCO 40–59% predicted15 (6)9 (4)
DLCO <40% predicted3 (1)0
Body plethysmography
 TLC L2145.9±1.51776.1±1.50.03
 TLC % predicted20292±1516694±150.02
 TLC <LLN21451 (24)17740 (23)0.64
Chest CT
 Any GGO241112 (46)
 GGO >10%24143 (18)
 Fibrotic-like findings24196 (40)
 Chest CT at both time points
 Any GGO12489 (72)12462 (50)<0.001
 GGO >10%12439 (31)12410 (8)< 0.001
 Fibrotic-like findings12481 (65)12474 (60)0.16

Data are presented as n (%) or mean±sd unless otherwise stated. Paired t-test for continuous variables, Wilcoxon sign rank test for ordinal variables, and McNemar's test for categorical variables. mMRC: modified Medical Research Council dyspnoea scale; 6MWD: 6-min walk distance; LLN: lower limit of normal; FVC: forced vital capacity; FEV1: forced expiratory volume in 1 s; DLCO: diffusion capacity of the lungs for carbon monoxide; TLC: total lung capacity; CT: computed tomography; GGO: ground-glass opacities; GGO >10%: >10% GGO in at least one lung zone; sd: standard deviation.